{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T11:40:44Z","timestamp":1712230844411},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T00:00:00Z","timestamp":1298419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00105-010-2079-4","type":"journal-article","created":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T22:24:59Z","timestamp":1298327099000},"page":"178-188","source":"Crossref","is-referenced-by-count":8,"title":["Versorgungsforschung am Beispiel Neurodermitis","Health services research the example of atopic dermatitis"],"prefix":"10.1007","volume":"62","author":[{"given":"J.","family":"Schmitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,23]]},"reference":[{"key":"2079_CR1","unstructured":"Pfaff H (2003) Versorgungsforschung \u2013 Begriffsbestimmung, Gegenstand und Aufgaben. In: Pfaff H, Schrappe M, Lauterbach KW et al (Hrsg) Gesundheitsversorgung und Disease Management. Grundlagen und Anwendungen der Versorgungsforschung. Hans Huber, Bern, S 13\u201324"},{"key":"2079_CR2","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1055\/s-2006-946608","volume":"131","author":"Pfaff","year":"2006","unstructured":"Pfaff H (2006) Health care research: the last mile in sight. Dtsch Med Wochenschr 131:1488\u20131490","journal-title":"Dtsch Med Wochenschr"},{"key":"2079_CR3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-0029-1234066","volume":"71","author":"Pfaff","year":"2009","unstructured":"Pfaff H, Glaeske G, Neugebauer EA, Schrappe M (2009) Memorandum III: \u201eMethods for Health Services Research\u201c (Part 1). Gesundheitswesen 71:505\u2013510","journal-title":"Gesundheitswesen"},{"key":"2079_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00103-005-1206-3","volume":"49","author":"Pfaff","year":"2006","unstructured":"Pfaff H, Kaiser C (2006) Tasks and development of health services research. A comparison between the USA, UK, Australia and Germany. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 49:111\u2013119","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"2079_CR5","unstructured":"Swart E, Ihle P (2005) Routinedaten im Gesundheitswesen \u2013 Handbuch Sekund\u00e4rdatenanalyse: Grundlagen, Methoden und Perspektiven. Hans Huber, Bern"},{"key":"2079_CR6","unstructured":"K\u00f6ster I, Ferber L von (1997) Interne Diagnosevalidierung. In: Ferber L von, Behrens J (Hrsg) Public Health Forschung mit Gesundheits- und Sozialdaten. Stand und Perspektiven. Asgard, Sankt Augustin, S 55\u201364"},{"key":"2079_CR7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00105-009-1709-1","volume":"60","author":"Schmitt","year":"2009","unstructured":"Schmitt J, Schmitt NM, Kirch W, Meurer M (2009) Significance of atopic dermatitis in outpatient medical care. Analysis of health care data from Saxony. Hautarzt 60:320\u2013327","journal-title":"Hautarzt"},{"key":"2079_CR8","first-page":"345","volume":"7","author":"Schmitt","year":"2009","unstructured":"Schmitt J, Schmitt NM, Kirch W, Meurer M (2009) Outpatient care and medical treatment of children and adults with atopic eczema. J Dtsch Dermatol Ges 7:345\u2013351","journal-title":"J Dtsch Dermatol Ges"},{"key":"2079_CR9","first-page":"879","volume":"7","author":"Schmitt","year":"2009","unstructured":"Schmitt J, Kirch W, Meurer M (2009) Auswirkungen der Einf\u00fchrung der Praxisgeb\u00fchr auf die ambulante Versorgung und Therapie des atopischen Ekzems. J Dtsch Dermatol Ges 7(10):879\u2013886","journal-title":"J Dtsch Dermatol Ges"},{"key":"2079_CR10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1610-0387.2009.07061.x","volume":"7","author":"Werfel","year":"2009","unstructured":"Werfel T, Aberer W, Augustin M et al (2009) Atopic dermatitis: S2 guidelines. J Dtsch Dermatol Ges 7(Suppl 1):S1\u2013S46","journal-title":"J Dtsch Dermatol Ges"},{"key":"2079_CR11","first-page":"327","volume":"110","author":"Niedner","year":"1992","unstructured":"Niedner R (1992) External administration of glucocorticosteroids. Part 1: Administration guidelines \u2013 classification. Fortschr Med 110:327\u2013329","journal-title":"Fortschr Med"},{"key":"2079_CR12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2340\/00015555-0207","volume":"87","author":"Schmitt","year":"2007","unstructured":"Schmitt J, Schakel K, Schmitt N, Meurer M (2007) Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol 87:100\u2013111","journal-title":"Acta Derm Venereol"},{"key":"2079_CR13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1468-3083.2006.02023.x","volume":"21","author":"Schmitt","year":"2007","unstructured":"Schmitt J, Schmitt NM, Meurer M (2007) Cyclosporin in the treatment of patients with atopic eczema \u2013 a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 21:606\u2013619","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2079_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","volume":"312","author":"Sackett","year":"1996","unstructured":"Sackett DL, Rosenberg WM, Gray JA et al (1996) Evidence based medicine: what it is and what it isn\u2019t. BMJ 312:71\u201372","journal-title":"BMJ"},{"key":"2079_CR15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.2009.09561.x","volume":"162","author":"Schmitt","year":"2009","unstructured":"Schmitt J, Schakel K, Folster-Holst R et al (2009) Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial. Br J Dermatol 162(3):661\u2013668","journal-title":"Br J Dermatol"},{"key":"2079_CR16","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jama.276.14.1172","volume":"276","author":"Russell","year":"1996","unstructured":"Russell LB, Gold MR, Siegel JE et al (1996) The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. JAMA 276:1172\u20131177","journal-title":"JAMA"},{"key":"2079_CR17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1017\/S0266462300008461","volume":"5","author":"Torrance","year":"1989","unstructured":"Torrance G, Feeny D (1989) Utilities and quality-adjusted life years. Int J Technol Assess Health Care 5:559\u2013575","journal-title":"Int J Technol Assess Health Care"},{"key":"2079_CR18","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMcp042803","volume":"352","author":"Williams","year":"2005","unstructured":"Williams HC (2005) Clinical practice. Atopic dermatitis. N Engl J Med 352:2314\u20132324","journal-title":"N Engl J Med"},{"key":"2079_CR19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.2007.08354.x","volume":"158","author":"Schmitt","year":"2007","unstructured":"Schmitt J, Meurer M, Klon M, Frick KD (2007) Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema \u2013 a population-based study. Br J Dermatol 158:351\u2013359","journal-title":"Br J Dermatol"},{"key":"2079_CR20","doi-asserted-by":"crossref","unstructured":"Gold MR, Siegel RG, Weinstein MC (1996) Cost-effectiveness in health and medicine. Oxford University Press, New York","DOI":"10.1093\/oso\/9780195108248.001.0001"},{"key":"2079_CR21","unstructured":"Drummond M, O\u2019Brien B, Stoddart GL, Torrance G (1998) Methods for the economic evaluation of health care programmes. Oxford Medical Publishers, Toronto"},{"key":"2079_CR22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00105-005-0898-5","volume":"56","author":"Zschocke","year":"2005","unstructured":"Zschocke I, Hammelmann U, Augustin M (2005) Therapeutischer Nutzen in der dermatologischen Behandlung. Hautarzt 56:839\u2013846","journal-title":"Hautarzt"},{"key":"2079_CR23","first-page":"461","volume":"69","author":"McAlister","year":"2002","unstructured":"McAlister RO, Tofte SJ, Doyle JJ et al (2002) Patient and physician perspectives vary on atopic dermatitis. Cutis 69:461\u2013466","journal-title":"Cutis"},{"key":"2079_CR24","first-page":"323","volume":"Pediatr","author":"Paller","year":"2002","unstructured":"Paller AS, McAlister RO, Doyle JJ, Jackson A (2002) Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment. Clin Pediatr (Phila) 41:323\u2013332","journal-title":"Clin"},{"key":"2079_CR25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1046\/j.0022-202x.2001.01475.x","volume":"117","author":"Ohya","year":"2001","unstructured":"Ohya Y, Williams H, Steptoe A et al (2001) Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol 117:852\u2013857","journal-title":"J Invest Dermatol"},{"key":"2079_CR26","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.clinthera.2006.10.004","volume":"28","author":"Lee","year":"2006","unstructured":"Lee WC, Balu S, Cobden D et al (2006) Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 28:1712\u20131725","journal-title":"Clin Ther"},{"key":"2079_CR27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.138.3.337","volume":"138","author":"Renzi","year":"2002","unstructured":"Renzi C, Picardi A, Abeni D et al (2002) Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 138:337\u2013342","journal-title":"Arch Dermatol"},{"key":"2079_CR28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000102029","volume":"215","author":"Schmitt","year":"2007","unstructured":"Schmitt JM, Ford DE (2007) Role of depression in quality of life for patients with psoriasis. Dermatology 215:17\u201327","journal-title":"Dermatology"},{"key":"2079_CR29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1610-0387.2007.06609.x","volume":"6","author":"Schmitt","year":"2008","unstructured":"Schmitt J, Csotonyi F, Bauer A, Meurer M (2008) Determinants of treatment goals and satisfaction of patients with atopic eczema. J Dtsch Dermatol Ges 6:458\u2013466","journal-title":"J Dtsch Dermatol Ges"},{"key":"2079_CR30","unstructured":"Jungblut-Wischmann P (2000) Allgemeine Kundenerwartungen. In: Eichhorn P, Seelos HJ, von der Schulenburg JM (Hrsg) Krankenhausmanagement. Urban & Fischer, M\u00fcnchen, S 683\u2013694"},{"key":"2079_CR31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.jaci.2007.08.011","volume":"120","author":"Schmitt","year":"2007","unstructured":"Schmitt J, Langan SM, Williams HC (2007) What are the best outcome measurements for atopic eczema? \u2013 A systematic review. J Allergy Clin Immunol 120:1389\u20131398","journal-title":"J Allergy Clin Immunol"},{"key":"2079_CR32","first-page":"198","volume":"25","author":"Boers","year":"1998","unstructured":"Boers M, Brooks P, Strand CV, Tugwell P (1998) The OMERACT filter for outcome measures in rheumatology. J Rheumatol 25:198\u2013199","journal-title":"J Rheumatol"},{"key":"2079_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1745-6215-8-38","volume":"8","author":"Tugwell","year":"2007","unstructured":"Tugwell P, Boers M, Brooks P et al (2007) OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 8:38","journal-title":"Trials"},{"key":"2079_CR34","unstructured":"Schmitt J, Langan S, Stamm T, Williams HC (2010) Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multi-perspective Delphi consensus process. J Invest Dermatol (published online Oct 14, 2010)"},{"key":"2079_CR35","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1365-2133.2010.10054.x","volume":"163","author":"Schmitt","year":"2010","unstructured":"Schmitt J, Williams HC (2010) Harmonising Outcome Measures for Eczema (HOME). Report from the first international consensus meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol 163(6):1166\u20131168","journal-title":"Br J Dermatol"},{"key":"2079_CR36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1365-2230.2000.00698.x","volume":"25","author":"Williams","year":"2000","unstructured":"Williams HC (2000) Epidemiology of atopic dermatitis. Clin Exp Dermatol 25:522\u2013529","journal-title":"Clin Exp Dermatol"},{"key":"2079_CR37","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","volume":"358","author":"Bieber","year":"2008","unstructured":"Bieber T (2008) Atopic dermatitis. N Engl J Med 358:1483\u20131494","journal-title":"N Engl J Med"},{"key":"2079_CR38","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2133.2009.09309.x","volume":"161","author":"Schmitt","year":"2009","unstructured":"Schmitt J, Romanos M, Pfennig A et al (2009) Psychiatric comorbidity in adult eczema. Br J Dermatol 161:878\u2013883","journal-title":"Br J Dermatol"},{"key":"2079_CR39","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jama.2009.136","volume":"301","author":"Schmitt","year":"2009","unstructured":"Schmitt J, Romanos M, Schmitt NM et al (2009) Atopic eczema and attention-deficit\/hyperactivity disorder in a population-based sample of children and adolescents. JAMA 301:724\u2013726","journal-title":"JAMA"},{"key":"2079_CR40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/jech.2009.093534","volume":"64","author":"Romanos","year":"2010","unstructured":"Romanos M, Gerlach M, Warnke A, Schmitt J (2010) Association of attention-deficit\/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J Epidemiol Community Health 64:269\u2013273","journal-title":"J Epidemiol Community Health"},{"key":"2079_CR41","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1398-9995.2010.02449.x","volume":"65","author":"Schmitt","year":"2010","unstructured":"Schmitt J, Buske-Kirschbaum A, Roessner V (2010) Is atopic disease a risk factor for attention-deficit\/hyperactivity disorder? A systematic review. Allergy 65(12):1506\u20131524","journal-title":"Allergy"},{"key":"2079_CR42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaci.2009.10.055","volume":"125","author":"Schmitt","year":"2010","unstructured":"Schmitt J, Apfelbacher C, Chen CM et al (2010) Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol 125:404\u2013410","journal-title":"J Allergy Clin Immunol"},{"key":"2079_CR43","doi-asserted-by":"crossref","unstructured":"Schmitt J, Chen CM, Apfelbacher C et al (2010) Infant eczema, infant sleeping problems and mental health at age 10 years: The prospective birth-cohort study LISAplus. Allergy (published online Sept 29, 2010)","DOI":"10.1055\/s-0030-1266250"},{"key":"2079_CR44","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1176\/appi.ajp.160.6.1028","volume":"160","author":"Linnet","year":"2003","unstructured":"Linnet KM, Dalsgaard S, Obel C et al (2003) Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 160:1028\u20131040","journal-title":"Am J Psychiatry"},{"key":"2079_CR45","first-page":"10","volume":"33","author":"Grizenko","year":"2008","unstructured":"Grizenko N, Shayan YR, Polotskaia A et al (2008) Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci 33:10\u201316","journal-title":"J Psychiatry Neurosci"},{"key":"2079_CR46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1749-6632.1998.tb09613.x","volume":"840","author":"Buske-Kirschbaum","year":"1998","unstructured":"Buske-Kirschbaum A, Jobst S, Hellhammer DH (1998) Altered reactivity of the hypothalamus-pituitary-adrenal axis in patients with atopic dermatitis: pathologic factor or symptom? Ann N Y Acad Sci 840:747\u2013754","journal-title":"Ann N Y Acad Sci"},{"key":"2079_CR47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000216190","volume":"16","author":"Buske-Kirschbaum","year":"2009","unstructured":"Buske-Kirschbaum A (2009) Cortisol responses to stress in allergic children: interaction with the immune response. Neuroimmunomodulation 16:325\u2013332","journal-title":"Neuroimmunomodulation"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-010-2079-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-010-2079-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-010-2079-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T11:25:37Z","timestamp":1712229937000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-010-2079-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,23]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["2079"],"URL":"https:\/\/doi.org\/10.1007\/s00105-010-2079-4","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,23]]}}}